Trials / Completed
CompletedNCT01360749
Efficacy and Safety of Lambdalina (Lidocaine Cream) Versus Placebo as an Anesthetic for Laser Hair Removal
Multicentre, Double-Blind Trial to Evaluate the Efficacy and Safety of Lambdalina vs Placebo as an Anesthetic for Laser Hair Removal
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 42 (actual)
- Sponsor
- ISDIN · Industry
- Sex
- Female
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
Double-blind, randomized, placebo-controlled trial to assess the efficacy of Lambdalina (lidocaine cream) in reducing pain associated with laser hair removal in women.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lambdalina® (Lidocaine 4% cream) | Lambdaline dose: 2 g for 10 cm2. |
| DRUG | Placebo | Placebo dose: 2 g for 10 cm2. |
Timeline
- Start date
- 2011-05-01
- Primary completion
- 2011-11-01
- Completion
- 2011-11-01
- First posted
- 2011-05-26
- Last updated
- 2012-04-13
Locations
2 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT01360749. Inclusion in this directory is not an endorsement.